Literature DB >> 16482425

Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients.

Lidia Kria1, Taoufik Khalfaoui, Ghada Mkannez, Omar Beltaief, Raja Anane, Khalil Errais, Lilia Tounsi, Raja Zhioua, Sarra Ben Jilani, Amel Meddeb Ouertani.   

Abstract

The expression pattern of VEGF, p53 and ICAM-1 was studied in conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination, including retinal fluorescein angiography. Indirect immunoperoxidase method was performed on 20 eyes of 20 patients with type II diabetes without DR and on 5 eyes of 5 patients with PDR. A control study was performed on 6 normal conjunctiva undertaken during cataract surgery. Immunoreactivity of VEGF, p53 and ICAM-1 was found in epithelial, fibroblast and vascular endothelial cells. For the same duration of diabetes, a strong to moderate or weak immunoreactivity was observed in the conjunctiva of patients without retinopathy. In patients with PDR, the expression was strong for all these proteins. The immunoreactivity was correlated between VEGF, p53 and ICAM-1. In the normal conjunctiva, a weak to negative immunostaining was observed. The presence of these proteins in the conjunctiva of diabetic patients without retinopathy may add new data in the pathogenesis of diabetic retinopathy. Further studies are needed to confirm this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482425     DOI: 10.1007/s10735-005-9002-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  38 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Authors:  Y Moromizato; S Stechschulte; K Miyamoto; T Murata; A Tsujikawa; A M Joussen; A P Adamis
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Growth factors and diabetic retinopathy.

Authors:  M Paques; P Massin; A Gaudric
Journal:  Diabetes Metab       Date:  1997-04       Impact factor: 6.041

Review 4.  Factors controlling ocular angiogenesis.

Authors:  R Casey; W W Li
Journal:  Am J Ophthalmol       Date:  1997-10       Impact factor: 5.258

Review 5.  Multiple roles of the tumor suppressor p53.

Authors:  Jill Bargonetti; James J Manfredi
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

6.  Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.

Authors:  D H Lee; H J Cho; J T Kim; J S Choi; C K Joo
Journal:  Cornea       Date:  2001-10       Impact factor: 2.651

7.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

8.  Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus.

Authors:  A R Rosa; C C Schirmer; R R Gurski; L Meurer; M I Edelweiss; C D Kruel
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

9.  Overexpression of p53 tumor suppressor gene in pterygia.

Authors:  O Weinstein; G Rosenthal; H Zirkin; T Monos; T Lifshitz; S Argov
Journal:  Eye (Lond)       Date:  2002-09       Impact factor: 3.775

10.  Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.

Authors:  P Esser; M Bresgen; R Fischbach; K Heimann; P Wiedemann
Journal:  Ger J Ophthalmol       Date:  1995-09
View more
  4 in total

1.  Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Nuria Basora; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2010-06-08       Impact factor: 2.611

2.  Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas.

Authors:  Toshiyuki Nakayama; Yang-Cheul Cho; Yuka Mine; Ayumi Yoshizaki; Shinji Naito; Chun-Yang Wen; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.

Authors:  Taoufik Khalfaoui; Gérard Lizard; Amel Ouertani-Meddeb
Journal:  J Mol Histol       Date:  2007-12-30       Impact factor: 2.611

4.  Egr1 mediates retinal vascular dysfunction in diabetes mellitus via promoting p53 transcription.

Authors:  Haocheng Ao; Bingqian Liu; Haichun Li; Lin Lu
Journal:  J Cell Mol Med       Date:  2019-03-19       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.